Join us on December 7th at 08:30 CET in Brussels for a panel discussion in collaboration with Bristol Myers Squibb.
The challenge facing EU lawmakers revising the General Pharmaceutical Legislation is to make regulatory rules today that can keep pace with science tomorrow. As technology and healthcare converge, how do we design regulatory rules with the flexibility that the future demands?
This event explores how the operating conditions in the EU can support future innovation.
When: Thursday 7th December 2023 08:30 CET.
Where: ALDE Party Secretariat, Rue d’Idalie 11, 1050 Brussels.
- Ondřej Knotek, MEP, European Parliament and TRANSFORM Alliance Chair.
- Dr Nikolai Brun, Chief Medical Officer, Affibody AB and former Chief Medicines Officer, Danish Medicines Agency.
- Magda Chelbus, Executive Director, Scientific and Regulatory Affairs, EFPIA.
- Dr Catherine Weil, Vice-President, Regulatory, International, Bristol Myers Squibb.